Newsletter
HTA Quarterly
Your quarterly guide to HTA news
HTA Quarterly is Cencora's quarterly newsletter distilling the latest in health technology assessment (HTA) worldwide. Each edition delivers expert perspectives on evidence requirements, assessment approaches, and policy shifts shaping market access, straight to your inbox every season.
Developed by global experts with deep local market knowledge, HTA Quarterly goes beyond the headlines to provide the insights and analysis you need to stay ahead of the priorities and perspectives shaping HTA today. Whether you're navigating evolving evidence requirements, monitoring payer expectations, or tracking policy and regulatory developments across key markets, HTA Quarterly keeps you informed and prepared.
Each edition covers a broad range of topics, including therapeutic area spotlights, geographic reviews, critical industry developments, and emerging evidence trends, giving you a comprehensive view of HTA activity around the globe, season after season.
Don't miss an edition. Subscribe today to receive Cencora's latest insights on global health technology assessment trends, evidence expectations, and market access directly to your inbox.
Developed by global experts with deep local market knowledge, HTA Quarterly goes beyond the headlines to provide the insights and analysis you need to stay ahead of the priorities and perspectives shaping HTA today. Whether you're navigating evolving evidence requirements, monitoring payer expectations, or tracking policy and regulatory developments across key markets, HTA Quarterly keeps you informed and prepared.
Each edition covers a broad range of topics, including therapeutic area spotlights, geographic reviews, critical industry developments, and emerging evidence trends, giving you a comprehensive view of HTA activity around the globe, season after season.
Don't miss an edition. Subscribe today to receive Cencora's latest insights on global health technology assessment trends, evidence expectations, and market access directly to your inbox.
Areas of focus
- European Health Technology Assessment regulation and its implementation: An in-depth look at the new European HTA regulation, its objectives, and how it is being rolled out across member states, including implications for pharmaceutical companies and healthcare systems.
- National policy updates and processes: Updates on key policy changes and procedural developments across European countries, with a focus on how these impact market access, reimbursement, and pricing strategies.
- Pricing reforms and legislative change analyses: Detailed analyses of recent and proposed reforms in pharmaceutical pricing and legislation, examining their potential effects on market dynamics and patient access.
- Case studies on the evolution of frameworks: Real-world examples showcasing how different countries or regions have adapted their health technology assessment frameworks and pricing models to meet evolving challenges.
- Therapeutic area spotlights: Focused discussions on specific therapeutic areas, highlighting unique market access challenges, innovations, and policy impacts within these fields.
- Reflections on stakeholder collaboration: Insights into the importance of collaboration between industry players, policymakers, healthcare providers, and patients in shaping effective healthcare solutions and policies.
- Lessons from milestone programs: Key takeaways from successful programs or initiatives that have driven meaningful change in healthcare access, affordability, or innovation.
Our editors
Editor-in-chief
Kellie Meyer, PharmD, MPH
Vice President, Evidence Generation & Value Communications
Managing co-editor
David Ringger, PhD
Director, Global Market Access & Pricing
Managing co-editor
Erika Wissinger, PhD
Sr. Director, Evidence Generation & Value Communications
Advisory board
- Herbert Altmann, PhD
VP | Market Access & Healthcare Consulting Europe | Cencora | Germany Tommy Bramley, PhD
Sr. Vice President | Global Consulting | Cencora | United Kingdom
- Andy Garnham, MSc
Sr. Director | Reimbursement | Cencora | United Kingdom
- Mike Drummond, PhD
Professor | Centre for Health Economics | University of York | United Kingdom - Belinda Yap, MPH, PhD
Director | Health Economics and Outcomes Research, Innomar Strategies | Cencora | Canada
